Psoriasis: A possible risk factor for development of coronary artery calcification

British Journal of Dermatology

Volumn 156, Issue 2, 2007, Pages 271-276

  Ludwig, R J ^a   Herzog, C ^a   Rostock, A ^a   Ochsendorf, F R ^a   Zollner, T M ^a   Thaci, D ^a   Kaufmann, R ^a   Vogl, T J ^a   Boehncke, W H ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cardiovascular diseases; Inflammation; Psoriasis; Spiral computed tomography

Indexed keywords

ADULT; ARTERY CALCIFICATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADULT; AGED; CALCINOSIS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846238954     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07562.x     Document Type: Article

References (28)

1. Schön M, Boehncke WH. Psoriasis - immunopathogenesis, genetics and therapeutic perspectives. N Engl J Med 2005; 352:1899-912.
2. Rapp SR, Feldman SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:401-7.
3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-95.
4. Maradit-Kremers H, Nicola PJ, Crowson CS et al. Cardiovascular death in rheumatoid arthritis. Arthritis Rheum 2005; 52:722-32.
5. McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N Engl J Med 1973; 288:912.
6. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978; 99:469-75.
7. Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 2001; 117:1531-7.
8. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19:225-30.
9. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988; 91:197-201.
10. Gupta MA, Gupta AK, Watteel GN. Cigarette smoking in men may be a risk factor for increased severity of psoriasis of the extremities. Br J Dermatol 1996; 135:859-60.
11. Binazzi M, Calandra P, Lisi P. Statistical association between psoriasis and diabetes: further results. Arch Dermatol Res 1975; 254:43-8.
12. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986; 172:298-304.
13. Seishima M, Seishima M, Mori S, Noma A. Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 1994; 130:738-42.
14. Flohr T, Ohnesorge B. Heart rate adaptive optimization of spatial and temporal resolution for electrocardiogram-gated multislice spiral CT of the heart. J Comput Assist Tomogr 2001; 25:907-23.
15. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-32.
16. Arad Y, Goodman KJ, Roth M et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St Francis Heart Study. J Am Coll Cardiol 2005; 46:158-65.
17. Arad Y, Spadaro LA, Roth M et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005; 46:166-72.
18. Pohle K, Ropers D, Geitner P et al. Analysis of coronary calcifications versus Framingham and PROCAM risk assessment in patients with a first myocardial infarction. Int J Cardiol 2006; 110:231-6.
19. Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96:3042-7.
20. Fukumoto Y, Shimokawa H, Ito A et al. Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. J Cardiovasc Pharmacol 1997; 29:222-31.
21. Leonardi CL, Powers JL, Metheson RT et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349:2014-22.
22. Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9:61-7.
23. Ludwig RJ, Schultz JE, Boehncke WH et al. Activated, but not resting platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004; 122:830-6.
24. Boehncke WH, Schön MP. Interfering with leukocyte rolling - a promising therapeutic approach in inflammatory skin disorders? Trends Pharmacol Sci 2003; 24:49-52.
25. Marongiu F, Sorano GG, Bibbo C et al. Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology 1994; 189:32-7.
26. Vanizor KB, Orem A, Cimsit G et al. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003; 332:23-30.
27. Schopf RE, Weber H, Morsches B. Enhanced procoagulant activity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis. Arch Dermatol Res 1993; 285:305-9.
28. Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res 2004; 114:321-7.